Acetylbritannilactone modulates microRNA-155-mediated inflammatory response in ischemic cerebral tissues

Molecular Medicine

Volumn 21, Issue , 2015, Pages 197-209

  Wen, Ya ^a,b,c   Zhang, Xiangjian ^a,b,c   Dong, Lipeng ^a,b   Zhao, Jingru ^a,b   Zhang, Cong ^a,b   Zhu, Chunhua ^a,b,c  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Hebei Key Laboratory for Neurology   (China)

^c Hebei Collaborative Innovation Center for Cardio cerebrovascular Disease   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLBRITANNILACTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LACTONE DERIVATIVE; MICRORNA 155; MYELOID DIFFERENTIATION FACTOR 88; SUPPRESSOR OF CYTOKINE SIGNALING 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACETYLBRITANNILATONE; LACTONE; MICRORNA; MIRN155 MICRORNA, HUMAN; SOCS1 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; GENE DELETION; GENE EXPRESSION; GENE OVEREXPRESSION; INFLAMMATION; LOW DRUG DOSE; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL LINE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; BRAIN ISCHEMIA; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; INFLAMMATION; LACTONES; MALE; MICE; MICE, KNOCKOUT; MICROGLIA; MICRORNAS; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING 1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TOLL-LIKE RECEPTOR 4;

EID: 84933506245     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2014.00199     Document Type: Article

References (42)

1. Macrez R, et al. (2011) Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 10:471-80.
2. Iadecola C, Anrather J. (2011) The immunology of stroke: from mechanisms to translation. Nat. Med. 17:796-808.
3. Jin R, Yang G, Li G. (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 87:779-89.
4. Morganti-Kossman MC, et al. (1997) Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Mol. Psychiatry. 2:133-6.
5. Blohmke CJ, et al. (2010) TLR5 as an antiinflammatory target and modifier gene in cystic fibrosis. J. Immunol. 185:7731-8.
6. Bsibsi M, Ravid R, Gveric D, van Noort JM. (2002) Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61:1013-21.
7. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. (1997) MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity. 7:837-47.
8. Yang Y, et al. (2007) Lipopolysaccharide (LPS) regulates TLR4 signal transduction in nasopharynx epithelial cell line 5-8F via NF-κB and MAPKs signaling pathways. Mol. Immunol. 44:984-92.
9. Takeda K, Akira S. (2004) TLR signaling pathways. Semin. Immunol. 16:3-9.
10. Xiao C, Rajewsky K. (2009) MicroRNA control in the immune system: basic principles. Cell. 136:26-36.
11. O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D. (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 10:111-22.
12. Ouyang YB, Stary CM, Yang GY, Giffard R. (2013) microRNAs: innovative targets for cerebral ischemia and stroke. Curr. Drug Targets. 14:90-101.
13. Nazari-Jahantigh M, et al. (2012) MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J. Clin. Invest. 122:4190-202.
14. Hunsberger JG, Fessler EB, Wang Z, Elkahloun AG, Chuang DM. (2012) Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia. Am. J. Transl. Res. 4:316-32.
15. Li T, et al. (2010) MicroRNAs modulate the non-canonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat. Immunol. 11:799-805.
16. Androulidaki A, et al. (2009) The kinase Akt1 controls macrophage response to lipopolysac-charide by regulating microRNAs. Immunity. 31:220-31.
17. Ceppi M, et al. (2009) MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 106:2735-40.
18. Whan Han J, et al. (2001) Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-kappaB. Br. J. Pharmacol. 133:503-12.
19. Han M, Wen JK, Zheng B, Zhang DQ. (2004) Acetylbritannilatone suppresses NO and PGE2 synthesis in RAW 264.7 macrophages through the inhibition of iNOS and COX-2 gene expression. Life Sci. 75:675-84.
20. Liu YP, Wen JK, Zheng B, Zhang DQ, Han M. (2007) Acetylbritannilactone suppresses lipopolysaccharide-induced vascular smooth muscle cell inflammatory response. Eur. J. Pharmacol. 577:28-34.
21. Liu B, Han M, Wen JK. (2008) Acetylbritannilactone inhibits neointimal hyperplasia after balloon injury of rat artery by suppressing nuclear factor-κB activation. J. Pharmacol. Exp. Ther. 324:292-8.
22. Liu B, et al. (2011) Acetylbritannilactone induces G1 arrest and apoptosis in vascular smooth muscle cells. Int. J. Cardiol. 149:30-8.
23. Yang C, Zhang X, Fan H, Liu Y. (2009) Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res. 1282:133-41.
24. Simonyi A, et al. (2005) Polyphenols in cerebral ischemia: novel targets for neuroprotection. Mol. Neurobiol. 31:135-47.
25. Kreutzberg GW. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:312-8.
26. Olson JK, Miller SD. (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173:3916-24.
27. Meng Z, Yan Z, Deng Q, Gao DF, Niu XL. (2013) Curcumin inhibits LPS-induced inflammation in RESEARCH ARTICLE rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways. Acta Pharmacol. Sin. 34:901-11.
28. Laird MH, et al. (2009) TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J. Leukoc. Biol. 85:966-77.
29. Wang Q, Tang XN, Yenari MA. (2007) The inflammatory response in stroke. J. Neuroimmunol. 184:53-68.
30. Kariko K, Weissman D, Welsh FA. (2004) Inhibition of toll-like receptor and cytokine signaling— a unifying theme in ischemic tolerance. J. Cereb. Blood Flow Metab. 24:1288-304.
31. Khan MM, et al. (2012) Alternatively-spliced extra domain A of fibronectin promotes acute inflammation and brain injury after cerebral ischemia in mice. Stroke. 43:1376-82.
32. Simard AR, Rivest S. (2007) Neuroprotective effects of resident microglia following acute brain injury. J. Comp. Neurol. 504:716-29.
33. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. (2011) Physiology of microglia. Physiol. Rev. 91:461-553.
34. Davies CA, et al. (1999) The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 19:87-98.
35. Medzhitov R. (2001) Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-45.
36. Yamamoto M, et al. (2002) Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature. 420:324-9.
37. Fitzgerald KA, et al. (2001) Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 413:78-83.
38. Kawai T, Akira S. (2007) Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13:460-9.
39. Nakagawa R, et al. (2002) SOCS-1 participates in negative regulation of LPS responses. Immunity. 17:677-87.
40. Rink C, Khanna S. (2011) MicroRNA in ischemic stroke etiology and pathology. Physiol. Genomics. 43:521-8.
41. Yin KJ, et al. (2010) Peroxisome proliferator-activated receptor delta regulation of miR-15a in is-chemia-induced cerebral vascular endothelial injury. J. Neurosci. 30:6398-408.
42. Yin KJ, et al. (2010) miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol. Dis. 38:17-26.